Heparin
Senator Schumer Proposes Track -And-Trace System For Prescription Drugs To Prevent Contamination
Tainted Heparin Linked To 81 Deaths; Blood Thinner Originating From China Contained Deadly Contaminant
April 22, 2008 -- WASHINGTON, DC--U.S. Senator Charles E. Schumer (D-NY) announced Tuesday he will introduce legislation this week establishing a modern track-and-trace system for all prescription drugs sold in the United States, a move he said would cut down on the contamination of popular patient medicines like the embattled blood thinner, heparin.
Heparin syringe: Photo by flaviab (CC) » read more »
Baxter's Multiple-dose Vial Heparin Linked to Severe Allergic Reactions
FDA advises health care practitioners to switch suppliers and limit use of drug until problem identified
February 11, 2008 -- The U.S. Food and Drug Administration (FDA) announced today that Baxter Healthcare Corporation has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of serious allergic reactions and hypotension (low blood pressure) in patients who receive high "bolus" doses of the drug. » read more »